AstraZeneca Research and Development Expenses 2010-2024 | AZN
AstraZeneca research and development expenses for the twelve months ending June 30, 2024 were $11.448B, a 10.49% increase year-over-year.
- AstraZeneca annual research and development expenses for 2023 were $10.935B, a 12.02% increase from 2022.
- AstraZeneca annual research and development expenses for 2022 were $9.762B, a 0.27% increase from 2021.
- AstraZeneca annual research and development expenses for 2021 were $9.736B, a 62.51% increase from 2020.